A Walk in the PARP: Therapeutic Strategies Targeting DNA Repair Defects in Prostate Cancer

Review an on-demand Webcast and download the slidesets from our symposia at ASCO GU 2019 and AUA 2019 to gain insights on PARP inhibitors in prostate cancer from oncology and urology experts, including overview of DNA repair deficiencies in prostate cancer, an update on the latest clinical data on PARP inhibitors for the treatment of prostate cancer, guidance on genetic testing, and a case discussion of where PARP inhibitors fit into the standard of care setting.
Celestia Higano Headshot
Celestia S. Higano, MD, FACP
Todd M. Morgan, MD
David A. Quigley, PhD
Charles J. Ryan, MD

Downloadable Slidesets

Download this slideset to review the clinical implications of genetic testing for DNA repair mutations in localized and advanced prostate cancer, including an expert case discussion.

Celestia Higano Headshot Celestia S. Higano, MD, FACP Todd M. Morgan, MD Released: February 14, 2019

Download this slideset to get up to date on the latest clinical evidence for PARP inhibition in the care of patients with advanced prostate cancer.

Charles J. Ryan, MD Released: February 14, 2019

Download this slideset to review the most clinically relevant DNA repair mutations in advanced prostate cancer and their implications for patient care.

David A. Quigley, PhD Released: February 14, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AstraZeneca
Clovis Oncology
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue